Invasive Cardiology near Fort Lee, NJ

Care Philosophy: My patients know that I'm here for them. Each patient that walks through the door receives the care I would want my parents or siblings to receive. If a patient leaves my office without a full understanding of the plan - including the reasoning - then I haven't done my job. Patients make better choices when they understand why we do the things we do.

Biography: Dr. Jacob Koruth, MD is a Cardiology Specialist who practices in New York, NY. He is 50 years old. Dr. Jacob Koruth, MD is affiliated with Mount Sinai Hospital.

Biography: Stefano Ravalli, MD is a cardiologist at Columbia University Medical Center/NewYork-Presbyterian Hospital. Dr. Ravalli's areas of expertise include coronary artery disease, hypertension, cardiac imaging, congestive heart failure and valvular heart disease. Dr. Ravalli is board certified in cardiovascular disease and is a Fellow of the American College of Cardiology. Dr. Ravalli received his medical degree from the University of Rome La Sapienza, where he graduated Summa cum laude. He completed his residency and internship at Beth Israel Medical Center in New York, cardiology and heart failure/transplant cardiology fellowships at Columbia University Medical Center. Dr. Ravalli has been named as a New York Super Doctor and US News & World Report's Best Doctors of America. Dr. Ravalli is an active preceptor at Columbia for medical student, residents and fellows and has authored more than 40 manuscripts and abstracts. Dr. Ravalli is a member of the ColumbiaDoctors Hypertension Center, a multi-disciplinary center of excellence that provides high quality care and state-of-the-art diagnostic testing for patients with hypertension. He sees patients at ColumbiaDoctors Midtown and Columbia University Medical Center in Washington Heights, New York.

Biography: Dr. Hasan Garan, MD is an Internist who practices in New York, NY. He is 79 years old and has been practicing for 51 years. Dr. Hasan Garan, MD is affiliated with Newyork-Presbyterian/Columbia University Medical Center.

Biography: Robert J. Sommer, MD, is an accomplished medical professional and Associate Professor of Medicine at Columbia University Irving Medical Center. He currently serves as the Director of Invasive Adult Congenital Heart Disease at Columbia's Interventional Cardiovascular Care program, based in Columbia University Irving Medical Center/NewYork-Presbyterian.Dr. Sommer's expertise lies in the areas of pediatric cardiology, adult congenital heart disease, and interventional cardiology. He is Board-certified in both Pediatric and Adult Congenital Heart Disease. He completed his training in pediatrics and pediatric cardiology at Mount Sinai Hospital in New York City and Boston Children's Hospital in Boston. CLINICAL WORKIn 1991, Dr. Sommer made significant contributions to the field by establishing the first comprehensive pediatric interventional catheterization laboratory in New York City. In 1999, he launched his own practice and redirected his focus towards the growing population of adult patients with congenital heart disease. Dr. Sommer's joined the faculty at Columbia University Irving Medical Center in 2005.Dr. Sommer has expertise in a diverse range of congenital and structural heart interventions. Dr. Sommer directs the Left Atrial Appendage Closure Team at Columbia, having participated in the PREVAIL Trial, the CAP2 registry, and the CHAMPION-AF Trials using the Watchman Device, as well as the Amulet Device Pivotal and Conformal Device Feasibility Trial. In addition to diagnostic catheterizations in complex congenital heart disease, he performs over 200 atrial septal defect and patent foramen ovale (PFO) closures and over 100 left atrial appendage closures annually. He has decades of experience in closing patent ductus arteriosus and ventricular septal defects, as well as, stenting coarctation of the aorta. Currently, Dr. Sommer serves as the national cardiology principal investigator for the GORE RELIEF clinical study to evaluate patent foramen ovale (PFO) closure for migraine headache relief using a device called the GORE CARDIOFORM Septal Occlude.Dr. Sommer collaborates closely with his Pediatric Cardiology colleagues at Columbia performing transcatheter pulmonary valve replacements in the congenital population. Together, with Barbara Robbins, NP, he provides primary cardiac care to a population of more than 300 pediatric and adult patients with congenital heart disease. Jointly, they manage more than 1500 office visits annually.

Care Philosophy: My goal is to provide excellence in the diagnosis and management of heart rhythm disorders nbsp;We strive to provide individualized care that is matched to a patient s condition by collaborating with the patient their physicians and when necessary o

Care Philosophy: New York, NY Oct 20, 2016 " As a Registered Nurse, I am very aware of excellence and lack there of..I must say Dr Sahar is excellent! His examination is thorough and he addressed all of my ...concerns in such a patient unhurried manner. he answered my questions...he is truly a Renaissance Physician and his practice is also an art."

Biography: Dr. S. Chiu Wong is a Professor of Medicine of the Greenberg Division of Cardiology in the Department of Medicine of the Weill Medical College of Cornell University. He is the Director of Cardiac Catheterization laboratories at the NewYork-Presbyterian/Weill Cornell Medical Center.Dr. Wong graduated Summa Cum Laude from Columbia College in May 1980 and received his Doctor of Medicine degree from Columbia University, College of Physicians and Surgeons in May 1984. Following his medical internship, residency, and clinical cardiology training at St. Luke's/Roosevelt Medical Center in New York City, he spent one additional stent fellowship year in 1991 under the tutorage of Dr. Richard Schatz at Scripps's Clinic and Research Foundation in La Jolla, California. He is board certified in Internal Medicine, Cardiovascular Disease and Interventional Cardiology.After his medical training, Dr. Wong joined the Cardiology Research Foundation at the Washington Hospital in 1992 and was appointed as Director of Coronary Stent Program in 1993. In 1995, Dr. Wong spearheaded a new cardiac catheterization program at the New York Hospital Medical Center of Queens where he assumed the directorship of coronary interventions. In October 1999, Dr. Wong was recruited to the New York Presbyterian Hospital - Cornell Campus as Director of Cardiac Catheterization Laboratories.Dr. Wong has published extensively in the field of interventional cardiology with special focus on new device angioplasty, saphenous vein graft intervention, cardiogenic shock, and drug eluting stent. His current clinical research interests include novel drug eluting stent designs, access site and PFO closure devices, percutaneous valve repair, and application of stem cell technology in the treatment of myocardial ischemia. In the past five years, Dr. Wong and his colleagues had participated in multiple US pivotal trials that led to the FDA approval of both drug eluting stents for the treatment of symptomatic obstructive coronary artery disease. Dr. Wong has recently served as the national principal investigation in the ECLIPSE trial which evaluated the safety and efficacy of an extra-vascular bio-degradable access site closure device in patients undergoing coronary or peripheral diagnostic/interventional procedures compare to the standard treatment of manual compression.Other exciting areas of ongoing research include percutaneous treatment valvular disease states including mitral regurgitation and aortic stenosis, assessment of novel pharmacologic agents to enhance safety of angioplasty procedures.His clinical research activities have been published in Journal of American College of Cardiology, American Journal of Cardiology, American heart Journal and he has presented his findings at numerous national and international meetings including American Heart Association, American College of Cardiology, Transcatheter Therapeutics, Summer in Seattle, Taiwan Society of Cardiology and Asia Pacific Cardiology Congress. He is recruited to serve as member of the Scientific Advisory Board of multiple major US medical device companies.

Biography: Christopher Irobunda, MD, is an Associate Professor at CUMC and an interventionalist. He is also Vice Chair of the Faculty Development focusing on Diversity, Equity & Inclusion within the Department of Medicine. He trained as a general and interventional cardiologist. Dr. Irobunda has been a full-time faculty since 2003. He obtained his MD/PhD in the Medical Scientist Training Program at the Albert Einstein College of Medicine in the Bronx, NY. His PhD was in Molecular Pharmacology, specifically on the cyclic Adenosine MonoPhosphate/beta-adrenergic signal transduction system. He subsequently completed an internship and residency in internal medicine at New York University Medical Center, followed by his General and Interventional Cardiology Fellowship here at Columbia University Medical Center. After completing his medical training and research study, he shifted his concentration to patient care and the education of aspiring young physicians. Dr. Irobunda is ardently dedicated to uncompromised patient care and teaching. His primary focus is individualized patient care and patient advocacy. Given his training as a medical scientist, it is hardly surprising that he is a keen diagnostician. He has a penchant for complex cardiac issues and other medical problems that can sometimes mask or aggravate the cardiac disease. His aptitude for unraveling these medical conundrums has led to medical diagnoses for patients who have come to him for second and even third opinions. However, above all else, his true genius is his ability to relate to his patients with intelligence, curiosity, patience, compassion, and humor. His ability to waylay even the most apprehensive of patients with his aura of reassurance and understanding has garnered him a continually growing medical practice. Again and again, individuals will refer family members and friends because of the empathy and level of care constantly provided. Indeed, his unceasing diligence has led him to become a physician member of Columbia University Medical Centers Patient Facilitated Services, an organization directed at patient satisfaction and outreach. Dr. Irobunda has also been the primary cardiologist for patients undergoing liver transplant evaluations at New York Presbyterian since 2004. When not in his private practice, he takes great pleasure in helping train the new influx of physicians in the only ethical way to practice medicinepatient-centered care. Dr. Irobunda has been a Supervisor and Attending Faculty for the Fundamentals of Clinical Medicine for First Year Medical Students at Columbia University College of Physicians and Surgeons since 2011, a program that endeavors to instill exceptional patient-doctor communication and trust. He encourages future medical practitioners to listen to the patient and learn to interpret and analyze the information being imported; to realize that the seemingly insignificant details sometimes lead to the culprit of an individual's illness. He has been a lecturer with International Postgraduate Organization for Knowledgetransfer, Research, and Teaching Excellent Students (IPOKRaTES) in Europe. IPOKRaTES offers opportunities for physicians from a plethora of countries to observe and gain instruction regarding differing methods in patient care practices. Since the summer of 2012, Dr. Irobunda has become involved in New York Presbyterian Hospital's Lange Youth Program, which seeks to prepare and enumerate the rigors of medical school for high school students. Dr. Irobunda is active in numerous community outreach organizations-Abyssian Baptist Church (NY), JP Morgan Chase Employee Education Program, Riverside Church Seniors, and Sister to Sister: The Women's Heart Health Foundation, to name a few. He seeks to educate the public on cardiovascular issues and ways to make everyday lifestyle modifications to help reduce these risks. In addition to being an interventional cardiologist who can perform angioplasties and stent placements, he emphasizes the prevention and treatment of heart disease through diet, exercise, and medical therapy.

Biography: Dr. Johanna Contreras, MD is a Cardiology Specialist who practices in New York, NY. She is 50 years old and has been practicing for 27 years. Dr. Johanna Contreras, MD is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Biography: Dr. Douglas Distefano, MD is a Cardiology Specialist who practices in New York, NY. He is 77 years old and has been practicing for 51 years. Dr. Douglas Distefano, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Bill Whang is a specialist in heart rhythm disorders. He has expertise in catheter ablation of atrial fibrillation and ventricular tachycardia, and works closely with colleagues who treat heart failure and adult congenital heart disease. He also has a clinical interest in left atrial appendage closure device implant. His research background is in epidemiology, and he has published on psychosocial factors in cardiac arrhythmia as well as on catheter ablation of arrhythmias. After medical school and residency at Columbia, he completed his cardiology and electrophysiology fellowships at Massachusetts General Hospital. He has been on the faculty since 2006.

Biography: Dr. Vivek Reddy, MD is a Cardiology Specialist who practices in New York, NY. He is 57 years old and has been practicing for 30 years. Dr. Vivek Reddy, MD is affiliated with Mount Sinai Hospital.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Biography: Dr. Prakash Krishnan, MD is an Interventional Cardiology Specialist who practices in New York, NY. He is 57 years old and has been practicing for 28 years. Dr. Prakash Krishnan, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.

Biography: Doctor Devereux is Director of the Adult Echocardiography Laboratory at the Weill Cornell Center of the New York Presbyterian Hospital. He has a long-standing clinical and research interest in cardiovascular connective tissue diseases, and has served as Chair of the Professional Advisory Committee of the National Marfan Foundation. In addition to expertise in all aspects of clinical echocardiography, Dr. Devereux conducts extensive research using cardiac ultrasound and other techniques to improve understanding of hypertensive heart disease, valvular heart diseases, cardiac effects of obesity diabetes, the prevalence and mechanisms of cardiovascular diseases in population-based samples and identify genes linked to and potentially responsible for a spectrum of cardiovascular diseases.A summary of Dr. Devereux's Education, Training and/or Faculty Appointments is listed as following:1971 M.D. - University of Pennsylvania School of Medicine1972 Intern, Internal Medicine - New York and Memorial Hospitals1974 Resident, Internal Medicine - New York and Memorial Hospitals1976 Fellow, Cardiology - Hospital of the University of Pennsylvania

Biography: Dr. Vishal Kapur, MD is an Interventional Cardiology Specialist who practices in New York, NY. He is 48 years old and has been practicing for 24 years. Dr. Vishal Kapur, MD is affiliated with Mount Sinai Morningside and Mount Sinai Hospital.